Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Nemaura Medical Revenue
In the fiscal year ending March 31, 2023, Nemaura Medical had annual revenue of $77.04K, down -84.71%.
Revenue
77.04K
Revenue Growth
-84.71%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
4.04K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| BioStem Technologies | 210.49M |
Nemaura Medical News
- 1 year ago - Important Update on Listing Status and Strategic Direction - GlobeNewsWire
- 1 year ago - Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - GlobeNewsWire
- 1 year ago - Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth - GlobeNewsWire
- 1 year ago - Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs - GlobeNewsWire
- 1 year ago - Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. - GlobeNewsWire
- 1 year ago - Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference - GlobeNewsWire
- 1 year ago - Nemaura Medical Provides Update on Nasdaq Compliance Status and Process - GlobeNewsWire